Jill L. Reiter
- Pollution top 10%
-
- HER2/EGFR in Cancer Research 9
- Reproductive Medicine top 10%
-
- RNA Research and Splicing 9
- RNA modifications and cancer 5
- RNA and protein synthesis mechanisms 4
- Glycosylation and Glycoproteins Research 3
- Peroxisome Proliferator-Activated Receptors 3
- Single-cell and spatial transcriptomics 2
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Nita J. MaihleGarrett M. BrodeurRoy GeronaPaul WinchesterShahid ParvezYunlong LiuAndre T. BaronC. David James
- Cited by
- PollutionCancer ResearchOncology
- Partner nations
- United StatesChinaPuerto Rico
In The Last Decade
Jill L. Reiter
35 papers receiving 831 citations
Peers
Comparison fields: 5 of 100
- Pollution 127
- Cancer Research 129
- Oncology 227
- Reproductive Medicine 58
- Molecular Biology 384
Countries citing papers authored by Jill L. Reiter
This map shows the geographic impact of Jill L. Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill L. Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill L. Reiter more than expected).
Fields of papers citing papers by Jill L. Reiter
This network shows the impact of papers produced by Jill L. Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill L. Reiter. The network helps show where Jill L. Reiter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jill L. Reiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 25 | |
| 7 | 2021 | 13 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 41 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 141 | |
| 15 | 2017 | 9 | |
| 16 | 2010 | 67 | |
| 17 | 2010 | 7 | |
| 18 | 2002 | 10 | |
| 19 | 2001 | 91 | |
| 20 | 1998 | 16 |
About Jill L. Reiter
Jill L. Reiter is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 35 papers that have together received 847 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), RNA Research and Splicing (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (4 papers), Glycosylation and Glycoproteins Research (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Pollution (127 citations), Cancer Research (129 citations) and Oncology (227 citations). Jill L. Reiter has collaborated with scholars based in United States, China and Puerto Rico. Frequent co-authors include Nita J. Maihle, Garrett M. Brodeur, Roy Gerona, Paul Winchester, Shahid Parvez, Yunlong Liu, Andre T. Baron, C. David James, Greg Eley and Jacqueline M. Lafky.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.